Shinichi Kawai
Shinichi Kawai publishes mostly in Rheumatology, Pharmacology and Molecular Biology, on topics such as Rheumatoid Arthritis Research and Therapies, Inflammatory mediators and NSAID effects and Systemic Lupus Erythematosus Research.
- World rank
- #2,342,381 of 7,710,434 ranked researchers
- Rank in Japan
- #45,955 of 383,136
- Works
- 300
- Citations
- 8.1k
- Citations per work
- 26.9
What does Shinichi Kawai research?
Shinichi Kawai's work is mostly in Medicine (35%), Biochemistry, Genetics and Molecular Biology (6%), Immunology and Microbiology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else16053.5%
- Health Sciences10635.3%
- Medicine10635.3%
- Life Sciences3411.2%
- 1Rheumatology18% of their works
- 2Pharmacology7% of their works
- 3Molecular Biology6% of their works
- 4Oncology5% of their works
- 5Immunology5% of their works
- 6Endocrinology, Diabetes and Metabolism5% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Inflammatory mediators and NSAID effects
- Systemic Lupus Erythematosus Research
- Monoclonal and Polyclonal Antibodies Research
- Estrogen and related hormone effects
- Chronic Lymphocytic Leukemia Research
- Autoimmune and Inflammatory Disorders Research
- Spondyloarthritis Studies and Treatments
Which keywords describe Shinichi Kawai's research?
The keywords of their largest research topics: Cardiovascular Risk, Inflammation, Autoantibodies, Biological Therapy, Rheumatoid Arthritis, Cancer, Cyclooxygenase-2 Inhibitors and Antiphospholipid Syndrome.
- Juvenile Idiopathic Arthritis
- Ankylosing Spondylitis
- Genomic Aberrations
- Chronic Lymphocytic Leukemia
- Fc Receptors
- Antiphospholipid Syndrome
- Cancer
- Biological Therapy
- Inflammation
- Cardiovascular Risk
- Autoantibodies
- Rheumatoid Arthritis
- Cyclooxygenase-2 Inhibitors
- Systemic Lupus Erythematosus
- Therapeutic Antibodies
- Estrogen
- Receptor
- Hemophagocytic Lymphohistiocytosis
- Spondyloarthritis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Cardiovascular Risk1162 topics
- Inflammation1162 topics
- Autoantibodies1072 topics
- Biological Therapy741 topic
- Rheumatoid Arthritis741 topic
- Cancer421 topic
- Cyclooxygenase-2 Inhibitors421 topic
- Antiphospholipid Syndrome331 topic
- Systemic Lupus Erythematosus331 topic
- Fc Receptors181 topic
- Therapeutic Antibodies181 topic
- Chronic Lymphocytic Leukemia161 topic
- Estrogen161 topic
- Genomic Aberrations161 topic
- Receptor161 topic
- Ankylosing Spondylitis151 topic
- Hemophagocytic Lymphohistiocytosis151 topic
- Juvenile Idiopathic Arthritis151 topic
- Spondyloarthritis151 topic
Where does Shinichi Kawai work?
Shinichi Kawai's main affiliation in the publication record is Toho University, Japan.
How many publications and citations does Shinichi Kawai have?
OpenAlex counts 300 works and 8,066 citations for Shinichi Kawai, an h-index of 45, ranking #2,342,381 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Shinichi Kawai
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Shinichi Kawai. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.